ReportAId is a technology company.
ReportAId has raised $2.0M across 1 funding round.
ReportAId has raised $2.0M in total across 1 funding round.
ReportAId is a Milan-based AI startup founded in 2024 that builds an AI-powered platform to interpret unstructured medical reports, transforming them into structured, actionable care plans, patient insights, and automated workflows.[1][2][3] It serves healthcare providers like hospitals and clinics, primarily in Europe, solving inefficiencies in fragmented clinical data, poor patient follow-up (where 70% of patients don't return to the same provider), and administrative delays by extracting key insights via natural language processing (NLP), integrating with CRMs or messaging tools like WhatsApp, and generating personalized care pathways while ensuring GDPR and EU AI Act compliance.[1][2][3] The company recently raised €2.2M in pre-seed funding led by Italian Founders Fund, with participation from Heartfelt, Exceptional Ventures, and others, to scale its team and expand integrations across public healthcare networks, already collaborating with Italy's leading healthcare groups to boost patient loyalty and hospital revenue by up to 25%.[1][2]
ReportAId was founded in 2024 in Milan by Giuseppe Faraci (CEO), Claudio Caletti (CTO), and Luca Foresti (Chairman), a team with over a decade of experience developing complex software for healthcare and diagnostics.[1][2][3][5] The idea emerged from observing a paradox in healthcare: abundant data from advanced diagnostics but outdated follow-up systems, leading to disconnected patient relationships and inefficiencies in care continuity.[3][5] Early traction came from working directly with Italian hospitals and leading healthcare groups, structuring medical reports into care plans and enabling thousands of daily patient interactions, which attracted €2.2M in pre-seed funding in late 2025 to fuel expansion.[1][2][5]
ReportAId rides the wave of AI-driven healthcare digitization, particularly in Europe where unstructured data in medical reports hampers 70-80% of clinical insights, amid rising demands for personalized care post-COVID and regulatory pushes like the EU AI Act.[1][2] Timing is ideal with exploding NLP advancements and healthcare's shift to patient-centric models, fueled by labor shortages and waiting-list crises; market forces like GDPR enforcement favor compliant tools that turn data into revenue and loyalty.[1][2] By structuring clinical data for public networks, it influences the ecosystem as a foundational layer, enabling better outcomes, efficiency, and scalability beyond Italy, much like how CRM revolutionized sales.[1][2][5]
ReportAId is poised to expand across European public healthcare, scaling integrations and team post-funding, with modules like drug intelligence and BI driving adoption in fragmented systems.[2] Trends like multimodal AI, telehealth growth, and value-based care will amplify its impact, potentially evolving it into a pan-European standard for clinical data orchestration. As it transforms reports into relationships, ReportAId exemplifies how AI solves healthcare's data paradox, turning inefficiency into a 25% revenue edge and sustained patient trust.[1]
ReportAId has raised $2.0M in total across 1 funding round.
ReportAId's investors include Exceptional Ventures, Luca Ascani.
ReportAId has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in May 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2025 | $2.0M Seed | Exceptional Ventures, Luca Ascani |